Blueprint Medicines (BPMC)
(Real Time Quote from BATS)
$88.00 USD
-2.27 (-2.52%)
Updated Sep 25, 2024 03:28 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (82 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.72 | 1.38 | 9.99 |
Current Quarter Estimate | -1.01 | 3.11 | 61.00 |
Year Ago Quarter Estimate | -2.20 | -4.81 | 54.84 |
Next Quarter Estimate | -0.88 | 3.91 | 63.00 |
Next Year Estimate | -1.84 | 24.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 84.23 | 17.70 | 15.67 |
Next Year | -39.39 | 9.90 | 11.34 |
Last 5 Years | -339.50 | 0.90 | 8.10 |
Next 5 Years | 34.00 | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.90 |
Price/Book (MRQ) | 17.86 | 2.05 |
Price/Cash Flow (MRFY) | NA | 16.44 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -56.64% | -154.18% |
Return on Equity (TTM) | -157.30% | -61.34% |
Debt to Equity (MRQ) | 1.06 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.